The National Institutes of Health, USA has released recommendations that provide a framework for a bold and transformative Alzheimer’s disease research agenda.
Path to Treatment and Prevention, the highly anticipated recommendations provide the wider Alzheimer’s research community with a strategy for speeding the development of effective interventions for Alzheimer’s and related dementias. These recommendations call for a change in how the academic, biopharmaceutical and government sectors participating in Alzheimer’s research and therapy generate, share and use knowledge to propel the development of critically needed therapies.
Related posts:
- Funded research provides new clues on how ApoE4 affects Alzheimer’s risk Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer’s disease, but the gene’s role in the disease has been unclear. Now, researchers funded by the National Institutes of Health have found that in mice, having the most risky variant of ApoE damages the blood vessels that feed the […]...
- Obama Administration Announces New Steps to Fight Alzheimer’s Disease The Obama Administration is making an additional $50 million available for cutting-edge Alzheimer’s research. The administration’s Fiscal Year 2013 budget will increase funding for Alzheimer’s research by $80 million, plus an additional $26 million for caregiver support, provider education and public awareness about the disease. This new funding will speed up the National Institutes of […]...
- Medicare Mouse study shows effect of blood pressure drug on Alzheimer’s disease A drug used decades ago to treat high blood pressure has been shown to improve learning and memory in mouse models of Alzheimer’s disease, according to a new study by researchers at the National Institute on Aging (NIA), part of the National Institutes of Health. The study found that the drug, diazoxide, acted on nerve […]...
- Medicare Card, NIH funds next step of cutting-edge research into Alzheimer’s disease genome Teams of scientists will use support from the National Institutes of Health to conduct research into the genetic underpinnings of Alzheimer’s disease, analyzing how genome sequences — the order of chemical letters in a cell’s DNA — may contribute to increased risk or protect against the disease. The NIH awarded grants for using innovative new […]...
- Medicare Card Replacement, Implementation Plans for Advisory Committee to the Director Recommendations on the Future Biomedical Research Workforce, Diversity in the Biomedical Research Workforce, and Data and Informatics NIH will present its implementation plans resulting from recommendations from three working groups of the Advisory Committee to the NIH Director (ACD)....
- Medicare, Alzheimer’s Disease Neuroimaging Initiative enters next phase of research The National Institutes of Health is expanding the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a groundbreaking study that will recruit hundreds of new volunteers to help define the subtle changes that may take place in the brains of older people many years before overt symptoms of Alzheimer’s disease appear. ADNI is the largest public-private partnership to […]...
- Medicare Card, Learn Symptoms and Treatment Options for Alzheimer’s Disease Medicare Card, Learn Symptoms and Treatment Options for Alzheimer's Disease...
- Medicare Card, Suppressing protein may stem Alzheimer’s disease process Medicare Card, Suppressing protein may stem Alzheimer's disease process...
- Medicare Card, Suppressing Protein May Stem Alzheimer’s Disease Process Medicare Card, Suppressing Protein May Stem Alzheimer’s Disease Process...
- Medicare Card, New evidence that viruses may play a role in Alzheimer’s disease Medicare Card, New evidence that viruses may play a role in Alzheimer’s disease...
- Research convenes national summit on The Science of Compassion: Future Directions in End-of-Life and Palliative Care The National Institute of Nursing Research (NINR), a component of the National Institutes of Health, and its partners will host The Science of Compassion: Future Directions in End-of-Life and Palliative Care. This trans-NIH summit aims to examine the current status of end-of-life and palliative care research and practice; propose strategies to address current barriers to […]...
- Medicare Card, Risk gene for Alzheimer’s disease associated with lower brain amyloid Medicare Card, Risk gene for Alzheimer’s disease associated with lower brain amyloid...
- Medicare Card, NIH-funded researchers create next-generation Alzheimer’s disease model Medicare Card, NIH-funded researchers create next-generation Alzheimer's disease model...
- Medicare Card, Study reveals how genetic changes lead to familial Alzheimer’s disease Medicare Card, Study reveals how genetic changes lead to familial Alzheimer’s disease...
- Medicare Card, DNA repair factor linked to breast cancer may also play a role in Alzheimer’s disease Medicare Card, DNA repair factor linked to breast cancer may also play a role in Alzheimer’s disease...